This is a combined synopsis/solicitation for commercial items prepared in accordance with the format in Subpart 12.6, as supplemented with additional information included in this notice. This requirement is subject to the availability of funds. This solicitation document and incorporated provisions and clauses are those in effect through Federal Acquisition Circular 2005-26. This acquisition is solicited on an unrestricted basis for NAIC 325412, size standard 750 employees. All responsible sources may submit a quotation which shall be considered by the agency. Federal Acquisition Regulation (FAR) provision 52.211-6 Brand Name or Equal applies to this acquisition. Vendors shall comply with FAR provision 52.211-6 if submitting other than the brand name products. Award will be all or none. FAR provision and clauses can be viewed at Internet Address: http//farsite.hill.af.mil/vffar1.htm.

The requirements of this solicitation are for Radiopharmaceutical Isotopes to be ordered on an as-needed basis during the period October 1, 2008 thru September 30, 2009. Delivery is to Federal Medical Center, Butner, North Carolina 27509, FOB destination

Item no. 0001: Radiopharmaceutical Isotopes

Salient Characteristics:

F-18 FDG 1-15 mCi: Fluorodeoxglucose-18, 1-15 mCi, radioactive positron emitter(true chemical form) utilized for Positron Emission imaging.